Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Astellas Pharma Inc announced today that it has entered into a strategic collaboration with Mass General Brigham that is focused on translational medicine and early development to establish an integrated approach to scientific advancement and clinica...
AVROBIO Inc and Tectonic Therapeutic Inc a privatelyheld biotechnology company developing GPCR targeted therapeutic proteins cofounded by Timothy A Springer and Andrew C Kruse of Harvard Medical School today announced that the companies have entered...
Vaxxinity Inc a US company pioneering the development of a new class of medicines today announced a research collaboration with the University of Floridas Center for Translational Research in Neurodegenerative Disease
Halozyme Therapeutics Inc today announced that Takeda received European Commission approval for HYQVIA coformulated with Halozymes ENHANZE drug delivery technology
Celltrion USA today announced the submission of Biologics License Application BLA to the US Food and Drug Administration FDA for CTP a biosimilar candidate of the reference product ACTEMRA
LAVA Therapeutics NV today announced that it has entered into a clinical trial collaboration and supply agreement with Merck Co Inc Rahway NJ USA to evaluate its antiPD therapy KEYTRUDA
Evaxion Biotech AS a clinicalstage TechBio company specializing in developing AIImmunology powered vaccines announces an expanded commitment to developing tailored cancer vaccines
Kyowa Kirin Co Ltd a Japanbased global specialty pharmaceutical company discovering and developing novel medicines utilizing the latest biotechnology and Orchard Therapeutics plc
Cybin Inc a clinicalstage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative nextgeneration psychedelic treatment options today announced that the US Food and Drug Administration
BlueRock Therapeutics LP a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG announced today that it has exercised its option to exclusively license OpCT an induced pluripotent stem
